
It is difficult to determine if the psychiatric symptoms that this patient experienced were due to a primary psychotic disorder versus occurring secondary to a previous medical condition. In considering the diagnosis of her symptoms occurring secondary to anti-GAD65 AE, we would expect an elevated level of anti-GAD antibodies, despite the patient receiving monthly IVIG treatments. Therefore, it was important to obtain a quantitative titer of anti-GAD65 in the patient while she was experiencing symptoms of psychosis
Like
Save
Share